Refining Risk for Alzheimer's Disease Among Heterozygous APOEÉ4 Carriers.
J Alzheimers Dis
; 94(2): 483-489, 2023.
Article
en En
| MEDLINE
| ID: mdl-37334598
ABSTRACT
In a large population-based cohort, we show not all heterozygous APOEÉ4 carriers are at increased risk for Alzheimer's disease (AD); a significantly higher AD proportion was only found for É3/É4, not É2/É4. Among É3/É4 carriers (24% in the cohort), the AD proportion differed considerably by polygenic risk score (PRS). In particular, the AD proportion was lower than the entire cohort for subjects in the bottom 20-percentile PRS and was higher than that of homozygous É4 carriers for subjects at the top 5th-percentile PRS. Family history was no longer a significant predictor of AD risk after adjusting APOE and PRS.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Enfermedad de Alzheimer
Tipo de estudio:
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Humans
Idioma:
En
Revista:
J Alzheimers Dis
Asunto de la revista:
GERIATRIA
/
NEUROLOGIA
Año:
2023
Tipo del documento:
Article
País de afiliación:
Estados Unidos